Landmark IOL approval
The British intraocular lens (IOL) manufacturer, Rayner Intraocular Lenses, has received pre-market approval (PMA) for its C-flex lens from the FDA making it the first non-US IOL to receive FDA approval in twenty years.
The British intraocular lens (IOL) manufacturer, Rayner Intraocular Lenses, has received pre-market approval (PMA) for its C-flex lens from the FDA making it the first non-US IOL to receive FDA approval in twenty years.
The C-flex injectable acrylic lenses have enhanced square edges to help reduce secondary cataract and the bio-comaptible Rayacryl material has an excellent track record on low affinity for silicone oil, sustained clarity and the absence of glare. Anti-vaulting haptics provide centration and help to prevent rotation and vaulting.
C-flex received CE mark approval in 2003.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
